Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Editas Medicine Inc (NASDAQ: EDIT) closed at $3.66 in the last session, down -2.92% from day before closing price of $3.77. In other words, the price has decreased by -$2.92 from its previous closing price. On the day, 2.17 million shares were traded. EDIT stock price reached its highest trading level at $3.75 during the session, while it also had its lowest trading level at $3.6.
Ratios:
We take a closer look at EDIT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 3.85. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2024, Upgraded its rating to Buy and sets its target price to $15 from $13 previously.
On May 09, 2024, Morgan Stanley Upgraded its rating to Equal-Weight which previously was Underweight but kept the price unchanged to $7.
Citigroup Upgraded its Neutral to Buy on October 24, 2023, while the target price for the stock was maintained at $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 04 ’24 when Mei Baisong sold 518 shares for $3.42 per share. The transaction valued at 1,774 led to the insider holds 133,895 shares of the business.
O’Neill Gilmore Neil sold 1,555 shares of EDIT for $5,325 on Sep 04 ’24. The CEO now owns 313,724 shares after completing the transaction at $3.42 per share. On Sep 03 ’24, another insider, O’Neill Gilmore Neil, who serves as the Officer of the company, bought 3,000 shares for $3.92 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 301863616 and an Enterprise Value of 61449756. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.50 while its Price-to-Book (P/B) ratio in mrq is 1.30. Its current Enterprise Value per Revenue stands at 0.917 whereas that against EBITDA is -0.297.
Stock Price History:
Over the past 52 weeks, EDIT has reached a high of $11.69, while it has fallen to a 52-week low of $3.40. The 50-Day Moving Average of the stock is -16.43%, while the 200-Day Moving Average is calculated to be -44.11%.
Shares Statistics:
According to the various share statistics, EDIT traded on average about 1.90M shares per day over the past 3-months and 2366750 shares per day over the past 10 days. A total of 81.77M shares are outstanding, with a floating share count of 81.70M. Insiders hold about 0.94% of the company’s shares, while institutions hold 69.52% stake in the company. Shares short for EDIT as of 1724976000 were 18005727 with a Short Ratio of 9.47, compared to 1722384000 on 16133636. Therefore, it implies a Short% of Shares Outstanding of 18005727 and a Short% of Float of 27.66.
